首页> 美国卫生研究院文献>British Heart Journal >Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population
【2h】

Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population

机译:在大量普通人群中血浆N端脑钠肽浓度对左心室收缩性心力衰竭的诊断和预后评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective: To evaluate N-terminal pro-brain natriuretic peptide (NT-proBNP) as a diagnostic and prognostic marker for systolic heart failure in the general population.>Design: Study participants, randomly selected to be representative of the background population, filled in a heart failure questionnaire and underwent pulse and blood pressure measurements, electrocardiography, echocardiography, and blood sampling and were followed up for a median (range) period of 805 (60−1171) days.>Setting: Participants were recruited from four randomly selected general practitioners and were examined in a Copenhagen university hospital.>Patients: 382 women and 290 men in four age groups (50−59 (n  =  174); 60−69 (n  =  204); 70−79 (n  =  174); ⩾ 80 years (n  =  120)).>Main outcome measures: Value of NT-proBNP in evaluating patients with symptoms of heart failure and impaired left ventricular (LV) systolic function; prognostic value of NT-proBNP for mortality and hospital admissions.>Results: In 38 (5.6%) participants LV ejection fraction (LVEF) was ⩽ 40%. NT-proBNP identified patients with symptoms of heart failure and LVEF ⩽ 40% with a sensitivity of 0.92, a specificity of 0.86, positive and negative predictive values of 0.11 and 1.00, and area under the curve of 0.94. NT-proBNP was the strongest independent predictor of mortality (hazard ratio (HR)  =  5.70, p < 0.0001), hospital admissions for heart failure (HR  =  13.83, p < 0.0001), and other cardiac admissions (HR  =  3.69, p < 0.0001). Mortality (26 v 6, p  =  0.0003), heart failure admissions (18 v 2, p  =  0.0002), and admissions for other cardiac causes (44 v 13, p < 0.0001) were significantly higher in patients with NT-proBNP above the study median (32.5 pmol/l).>Conclusions: Measurement of NT-proBNP may be useful as a screening tool for systolic heart failure in the general population.
机译:>目的:要评估N末端前脑利钠肽(NT-proBNP)作为普通人群收缩性心力衰竭的诊断和预后指标。>设计: ,随机选择代表背景人群,填写心力衰竭调查表并进行脉搏和血压测量,心电图,超声心动图和血液采样,并随访其中位(范围)为805(60−1171) >设置:。参与者是从四名随机选择的全科医生中招募的,并在哥本哈根大学医院接受了检查。>患者:四个年龄段的382名女性和290名男性(50- 59(n = 174); 60−69(n = 204); 70−79(n = 174); 80年(n = 120))。>主要结果指标: NT-的价值proBNP用于评估具有心力衰竭症状和左心室(LV)收缩功能受损的患者; NT-proBNP对死亡率和住院率的预后价值。>结果:在38名(5.6%)参与者中,LV射血分数(LVEF)为⩽40%。 NT-proBNP识别出患有心力衰竭和LVEF≥40%的患者,敏感性为0.92,特异性为0.86,阳性和阴性预测值分别为0.11和1.00,曲线下面积为0.94。 NT-proBNP是死亡率的最强独立预测因子(危险比(HR)= 5.70,p <0.0001),因心力衰竭入院(HR = 13.83,p <0.0001)和其他心脏入院(HR = 3.69,p < 0.0001)。 NT-proBNP高于25%的患者的死亡率(26 v 6,p = 0.0003),心力衰竭入院(18 v 2,p = 0.0002)和其他心脏原因的入院(44 v 13,p <0.0001)显着更高研究中位数(32.5 pmol / l)。>结论:测量NT-proBNP可能作为一般人群收缩性心力衰竭的筛查工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号